Cross interference with TNF-α-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 7, 2009, Pages 1156-1164

  Shin, Myoung Sook ^a   Shinghirunnusorn, Pattama ^a   Sugishima, Yumiko ^a   Nishimura, Miki ^a   Suzuki, Shunsuke ^a   Koizumi, Keiichi ^a   Saiki, Ikuo ^a   Sakurai, Hiroaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

EGFR; p38; TAB1; TAK1; TNF

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA ACTIVATED KINASE1; TRANSFORMING GROWTH FACTOR ALPHA ACTIVATED KINASE1 BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPIDERMAL GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY; LUCIFERASES; MAP KINASE KINASE KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649403120     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.04.005     Document Type: Article

References (54)

1. Shirakabe K., Yamaguchi K., Shibuya H., Irie K., Matsuda S., Moriguchi T., Gotoh Y., Matsumoto K., and Nishida E. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272 (1997) 8141-8144
2. Moriguchi T., Kuroyanagi N., Yamaguchi K., Gotoh Y., Irie K., Kano T., Shirakabe K., Muro Y., Shibuya H., Matsumoto K., Nishida E., and Hagiwara M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271 (1996) 13675-13679
3. Ninomiya Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 (1999) 252-256
4. Sakurai H., Miyoshi H., Toriumi W., and Sugita T. Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J. Biol. Chem. 274 (1999) 10641-10648
5. Sakurai H., Shigemori N., Hasegawa K., and Sugita T. TGF-beta-activated kinase 1 stimulates NF-kappaB activation by an NF-kappa B-inducing kinase-independent mechanism. Biochem. Biophys. Res. Commun. 243 (1998) 545-549
6. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., Ninomiya Tsuji J., and Matsumoto K. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5 (2000) 649-658
7. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
8. Jiang Z., Ninomiya Tsuji J., Qian Y., Matsumoto K., and Li X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22 (2002) 7158-7167
9. Takaesu G., Surabhi R.M., Park K.J., Ninomiya Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326 (2003) 105-115
10. Cheung P.C., Campbell D.G., Nebreda A.R., and Cohen P. Feedback control of the protein kinase TAK1 by SAPK2α/p38alpha. EMBO J. 22 (2003) 5793-5805
11. Ishitani T., Takaesu G., Ninomiya Tsuji J., Shibuya H., Gaynor R.B., and Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22 (2003) 6277-6288
12. Wan Y.Y., Chi H., Xie M., Schneider M.D., and Flavell R.A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 7 (2006) 851-858
13. Liu H.H., Xie M., Schneider M.D., and Chen Z.J. Essential role of TAK1 in thymocyte development and activation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11677-11682
14. Sato S., Sanjo H., Tsujimura T., Ninomiya Tsuji J., Yamamoto M., Kawai T., Takeuchi O., and Akira S. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells. Int. Immunol. 18 (2006) 1405-1411
15. Sato S., Sanjo H., Takeda K., Ninomiya Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
16. Omori E., Matsumoto K., Sanjo H., Sato S., Akira S., Smart R.C., and Ninomiya Tsuji J. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J. Biol. Chem. 281 (2006) 19610-19617
17. Sayama K., Hanakawa Y., Nagai H., Shirakata Y., Dai X., Hirakawa S., Tokumaru S., Tohyama M., Yang L., Sato S., Akira S., and Hashimoto K. Transforming growth factor-beta-activated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis. J. Biol. Chem. 281 (2006) 22013-22020
18. Uemura N., Kajino T., Sanjo H., Sato S., Akira S., Matsumoto K., and Ninomiya Tsuji J. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB. J. Biol. Chem. 281 (2006) 7863-7872
19. Wan J., Sun L., Mendoza J.W., Chui Y.L., Huang D.P., Chen Z.J., Suzuki N., Suzuki S., Yeh W.C., Akira S., Matsumoto K., Liu Z.G., and Wu Z. Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1. Mol. Cell. Biol. 24 (2004) 192-199
20. Wu X., and Sun S.C. Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK. EMBO Rep. 8 (2007) 510-515
21. Suzuki S., Singhirunnusorn P., Mori A., Yamaoka S., Kitajima I., Saiki I., and Sakurai H. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB. J. Biol. Chem. 282 (2007) 25177-25181
22. Zhang D., Gaussin V., Taffet G.E., Belaguli N.S., Yamada M., Schwartz R.J., Michael L.H., Overbeek P.A., and Schneider M.D. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6 (2000) 556-563
23. Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., and Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272 (1996) 1179-1182
24. Sakurai H., Miyoshi H., Mizukami J., and Sugita T. Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1. FEBS Lett. 474 (2000) 141-145
25. Singhirunnusorn P., Suzuki S., Kawasaki N., Saiki I., and Sakurai H. Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280 (2005) 7359-7368
26. Kajino T., Ren H., Iemura S., Natsume T., Stefansson B., Brautigan D.L., Matsumoto K., and Ninomiya Tsuji J. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J. Biol. Chem. 281 (2006) 39891-39896
27. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
28. Mendelsohn J., and Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 19 (2000) 6550-6565
29. Garcia Lloret M.I., Yui J., Winkler Lowen B., and Guilbert L.J. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J. Cell. Physiol. 167 (1996) 324-332
30. Fischer O.M., Hart S., Gschwind A., and Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31 (2003) 1203-1208
31. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., Tamai Y., Kurisaki T., Sehara Fujisawa A., Ohno S., and Mekada E. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17 (1998) 7260-7272
32. Tsai W., Morielli A.D., and Peralta E.G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 16 (1997) 4597-4605
33. Daub H., Weiss F.U., Wallasch C., and Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379 (1996) 557-560
34. Cheng H., Kartenbeck J., Kabsch K., Mao X., Marques M., and Alonso A. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol. J. Cell. Physiol. 192 (2002) 234-243
35. Chen W.N., Woodbury R.L., Kathmann L.E., Opresko L.K., Zangar R.C., Wiley H.S., and Thrall B.D. Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J. Biol. Chem. 279 (2004) 18488-18496
36. Argast G.M., Campbell J.S., Brooling J.T., and Fausto N. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279 (2004) 34530-34536
37. Ueno Y., Sakurai H., Matsuo M., Choo M.K., Koizumi K., and Saiki I. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. Br. J. Cancer 92 (2005) 1690-1695
38. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell. Biol. 6 (2005) 32-43
39. Zwang Y., and Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25 (2006) 4195-4206
40. Singhirunnusorn P., Ueno Y., Matsuo M., Suzuki S., Saiki I., and Sakurai H. Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway. J. Biol. Chem. 282 (2007) 12698-12706
41. De Luca A., Carotenuto A., Rachiglio A., Gallo M., Maiello M.R., Aldinucci D., Pinto A., and Normanno N. The role of the EGFR signaling in tumor microenvironment. J. Cell. Physiol. 214 (2008) 559-567
42. Szlosarek P., Charles K.A., and Balkwill F.R. Tumour necrosis factor-alpha as a tumour promoter. Eur. J. Cancer 42 (2006) 745-750
43. Kievit W., Fransen J., Oerlemans A.J., Kuper H.H., van der Laar M.A., de Rooij D.J., De Gendt C.M., Ronday K.H., Jansen T.L., van Oijen P.C., Brus H.L., Adang E.M., and van Riel P.L. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann. Rheum. Dis. 66 (2007) 1473-1478
44. Marshall J. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer 107 (2006) 1207-1218
45. Fanger G.R., Johnson N.L., and Johnson G.L. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J. 16 (1997) 4961-4972
46. App H., Hazan R., Zilberstein A., Ullrich A., Schlessinger J., and Rapp U. Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor. Mol. Cell. Biol. 11 (1991) 913-919
47. Ninomiya Tsuji J., Kajino T., Ono K., Ohtomo T., Matsumoto M., Shiina M., Mihara M., Tsuchiya M., and Matsumoto K. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278 (2003) 18485-18490
48. Mendoza H., Campbell D.G., Burness K., Hastie J., Ronkina N., Shim J.H., Arthur J.S., Davis R.J., Gaestel M., Johnson G.L., Ghosh S., and Cohen P. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem J. 409 (2008) 711-722
49. Sakurai H., Chiba H., Miyoshi H., Sugita T., and Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274 (1999) 30353-30356
50. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., and Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278 (2003) 36916-36923
51. Komatsu Y., Shibuya H., Takeda N., Ninomiya Tsuji J., Yasui T., Miyado K., Sekimoto T., Ueno N., Matsumoto K., and Yamada G. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119 (2002) 239-249
52. Yu Y., Ge N., Xie M., Sun W., Burlingame S., Pass A.K., Nuchtern J.G., Zhang D., Fu S., Schneider M.D., Fan J., and Yang J. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFκB and AP-1 activation as well as IL-6 gene expression. J. Biol. Chem. 283 (2008) 24497-24505
53. Ge B., Gram H., Di Padova F., Huang B., New L., Ulevitch R.J., Luo Y., and Han J. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 295 (2002) 1291-1294
54. Ge B., Xiong X., Jing Q., Mosley J.L., Filose A., Bian D., Huang S., and Han J. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J. Biol. Chem. 278 (2003) 2286-2293